JOHN VASIL: Open Payments
NPI 1629089982 · NORTHERN CAMBRIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 47 payments from 15 companies in 2025. Trend: 2023 $1,364 · 2024 $1,340 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $255 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Exact Sciences Corporation | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Lilly USA, LLC | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Wegovy, JARDIANCE, Ozempic, Cologuard Collection Kit, VOQUEZNA, QULIPTA.
Industry payments across PA — which companies pay providers there.
